REIN THERAPEUTICS INC (RNTX:NASDAQ)

$0.993 -0.037 (-3.5922%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed REIN THERAPEUTICS INC (RNTX:NASDAQ) News Sources

Palo Alto upgraded, Li Auto downgraded: Wall Street's top analyst calls

19-08-2025

yahoo.com

Rein Therapeutics Announces Publication of New Translational Data in iScience on Company’s Novel Therapy for Idiopathic Pulmonary Fibrosis

17-09-2025

yahoo.com

Rein Therapeutics Receives European Regulatory Approval to Initiate Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

09-10-2025

yahoo.com

Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

03-11-2025

yahoo.com

Rein Therapeutics Announces New Scientific Publication Demonstrating LTI-03 May Reduce Lung Scarring and Protect Cells Needed for Lung Repair in IPF

06-11-2025

yahoo.com

Rein Therapeutics Receives Orphan Drug Designation from European Medicines Agency for Lead Drug Candidate in Idiopathic Pulmonary Fibrosis

20-01-2026

yahoo.com

Rein Therapeutics Doses First Patient in Phase 2 Trial of LTI-03 for Idiopathic Pulmonary Fibrosis

03-03-2026

yahoo.com

Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis

29-04-2026

yahoo.com

Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock

01-05-2026

yahoo.com

Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option

18-05-2026

yahoo.com

REIN THERAPEUTICS INC (RNTX:NASDAQ) Sentiment Trend

0 25 50 75 100 2 86 83 80 84 70 88 88 87 61 19-08-2025 17-09-2025 09-10-2025 03-11-2025 06-11-2025 20-01-2026 03-03-2026 29-04-2026 01-05-2026 18-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

REIN THERAPEUTICS INC (RNTX:NASDAQ) FAQs

toggle

What is the current price of REIN THERAPEUTICS INC (RNTX:NASDAQ)?

The current price of REIN THERAPEUTICS INC (RNTX:NASDAQ) is $0.993.


toggle

REIN THERAPEUTICS INC (RNTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is $-0.037.


toggle

REIN THERAPEUTICS INC (RNTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of REIN THERAPEUTICS INC (RNTX:NASDAQ) since the previous trading day is -3.5922%.


toggle

What is the most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ)?

The most recent average sentiment score for REIN THERAPEUTICS INC (RNTX:NASDAQ) is 73 out of 100.


toggle

What is the most recent average sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ)?

The most recent sentiment for REIN THERAPEUTICS INC (RNTX:NASDAQ) is .


SEC-8K** Filing Available For REIN THERAPEUTICS INC (RNTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.